Comparison of the performance of the CRUSADE, ACUITY-HORIZONS, and ACTION bleeding risk scores in STEMI undergoing primary PCI: Insights from a cohort of 1391 patients

European Heart Journal: Acute Cardiovascular Care

Volumn 2, Issue 1, 2013, Pages 19-26

  Flores Rios X ^a   Couto Mallon D ^a   Rodriguez Garrido J ^a   Garcia Guimaraes M ^a   Gargallo Fernandez P ^a   Pinon Esteban P ^a   Aldama Lopez G ^a   Salgado Fernandez J ^a   Calvino Santos R ^a   Vazquez Gonzalez N ^a   Castro Beiras, A ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

Bleeding; ischaemic heart disease; myocardial infarction; primary percutaneous coronary intervention; risk score

Indexed keywords

EID: 84990328575     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872612469885     Document Type: Article

References (22)

1. Steg PG, Huber K, Andreotti F, et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J 2011; 32: 1854–1864.
2. Manoukian SV. Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction. Am J Cardiol 2009; 104(5 Suppl): 9C–15C.
3. Subherwal S, Bach RG, Chen AY, et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation 2009; 119: 1873–1882.
4. Mehran R, Pocock SJ, Nikolsky E, et al. A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol 2010; 55: 2556–2566.
5. Mathews R, Peterson ED, Chen AY, et al. In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry(R)-GWTG. Am J Cardiol 2011; 107: 1136–1143.
6. Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2999–3054.
7. Thygesen K, Alpert JS and White HD. Universal definition of myocardial infarction. Eur Heart J 2007; 28: 2525–2538.
8. Barge-Caballero E, Vazquez-Rodriguez JM, Estevez-Loureiro R, et al. Primary angioplasty in Northern Galicia: care changes and results following implementation of the PROGALIAM protocol. Revista Espanola de Cardiologia 2012; 65: 341–349.
9. Estevez-Loureiro R, Calvino-Santos R, Vazquez-Rodriguez JM, et al. Direct transfer of ST-elevation myocardial infarction patients for primary percutaneous coronary intervention from short and long transfer distances decreases temporal delays and improves short-term prognosis: the PROGALIAM Registry. EuroIntervention 2010; 6: 343–349.
10. Barge-Caballero E, Vazquez-Rodriguez JM, Estevez-Loureiro R, et al. Prevalence, etiology and outcome of catheterization laboratory false alarms in patients with suspected ST-elevation myocardial infarction. Revista Espanola de Cardiologia 2010; 63: 518–527.
11. Prada-Delgado O, Estevez-Loureiro R, Calvino-Santos R, et al. Safety and efficacy of femoral vascular closure devices in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. Am Heart J 2011; 161: 1207–1213.
12. Cockcroft DW and Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41.
13. Nunez E, Steyerberg EW and Nunez J. [Regression modeling strategies]. Revista Espanola de Cardiologia. 2011; 64: 501–507.
14. DeLong ER, DeLong DM and Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837–845.
15. Wang TY, Chen AY, Peterson ED, et al. Impact of home warfarin use on treatment patterns and bleeding complications for patients with non-ST-segment elevation acute coronary syndromes: observations from the CRUSADE quality improvement initiative. Eur Heart J 2008; 29: 1103–1109.
16. Amoroso G and Kiemeneij F. Transradial access for primary percutaneous coronary intervention: the next standard of care? Heart 2010; 96: 1341–1314.
17. Vink MA, Amoroso G, Dirksen MT, et al. Routine use of the transradial approach in primary percutaneous coronary intervention: procedural aspects and outcomes in 2209 patients treated in a single high-volume centre. Heart 2011; 97: 1938–1942.
18. Jolly SS, Yusuf S, Cairns J, et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet 2011; 377: 1409–1420.
19. Jepsen P, Johnsen SP, Gillman MW, et al. Interpretation of observational studies. Heart 2004; 90: 956–960.
20. Montalescot G, Gallo R, White HD, et al. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (Safety and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial. JACC Cardiovasc Interv 2009; 2: 1083–1091.
21. Nikolsky E, Mehran R, Dangas G, et al. Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach. Eur Heart J 2007; 28: 1936–1945.
22. Abu-Assi E, Gracia-Acuna JM, Ferreira-Gonzalez I, et al. Evaluating the Performance of the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines (CRUSADE) bleeding score in a contemporary Spanish cohort of patients with non-ST-segment elevation acute myocardial infarction. Circulation 2010; 121: 2419–2426.